A subscription to JoVE is required to view this content. Sign in or start your free trial.

Research Article

Elastography-Based Evaluation of Treatment Response Following Radiofrequency Ablation of Thyroid Nodules

60 views

DOI:

10.3791/71118

July 17th, 2026

In This Article

Summary

A standardized shear-wave and strain elastography follow-up protocol was applied before and after thyroid nodule radiofrequency ablation to quantify stiffness changes longitudinally. Using mixed-effects modeling and multivariable regression, early post-ablation elastography changes were independently associated with 12-month volume reduction response.

Abstract

Radiofrequency ablation (RFA) is an established minimally invasive treatment for benign thyroid nodules, yet response assessment relies largely on delayed volume reduction, limiting early post-procedural decision-making. In this retrospective cohort, participants with a single index thyroid nodule underwent standardized B-mode ultrasound and elastography at baseline, immediately post-ablation, and at 1, 3, 6, and 12 months. Shear-wave elastography (SWE) stiffness and strain ratio were acquired using prespecified regions of interest and quality-control criteria. Twelve-month response was defined by a volume reduction ratio (VRR) ≥ 50%. Longitudinal changes were evaluated using linear mixed-effects models, and immediate post-RFA elastography changes (immediate minus baseline) were related to 12-month VRR using correlation and multivariable regression adjusted for baseline nodule volume, nodule composition, delivered energy, and age. Among the 187 included participants, 146 were responders, and 41 were non-responders. SWE increased immediately after RFA in responders (31.5 ± 5.1 kPa to 41.7 ± 5.6 kPa) and non-responders (35.1 ± 5.3 kPa to 43.4 ± 5.8 kPa), followed by progressive decline with lower 12-month SWE in responders than non-responders (21.6 ± 4.7 vs 31.2 ± 5.2 kPa). VRR separated early, with 12-month VRR of 73.6 ± 6.9% in responders versus 38.5 ± 8.7% in non-responders. In mixed-effects models, the immediate SWE increase was significant (estimate +10.22 kPa, P < 0.001), and late group divergence was evident (non-responder × 12 months estimate +9.41 kPa, P < 0.001). Early elastography change correlated with 12-month VRR (Δstrain ratio: r = 0.445, P < 0.001; ΔSWE: r = 0.302, P < 0.001) and remained independently associated with VRR in adjusted models (Δstrain ratio β = 14.80% per +1.0, P < 0.001; ΔSWE β = 1.80% per +5 kPa, P = 0.011). Immediate post-RFA elastography changes capture early tissue effects and provide independent prognostic information for 12-month volumetric response.

Introduction

Thyroid nodules have become a defining “disease of detection” in modern endocrine practice, not because their biology has abruptly changed, but because imaging has made the thyroid exquisitely visible1,2,3. The measured prevalence depends strongly on how nodules are sought: classic epidemiologic syntheses estimate 2%–6% by palpation, approximately 19%–35% by ultrasound, and up to about 8%–65% in autopsy series, illustrating how method sensitivity reshapes the apparent epidemiology1. In iodine-deficient settings and with hi....

Access restricted. Please log in or start a trial to view this content.

Protocol

Ethics statement
All procedures involving human participants were conducted in accordance with the institutional guidelines of Xingtai Hospital and in compliance with the principles of the Declaration of Helsinki and its later amendments. The study was reviewed and approved by the Human Research Ethics Committee of Xingtai Hospital; because all participants provided standard written clinical informed consent for RFA and ultrasound examinations as part of routine care, the committee approved the study with a waiver of additional written research consent and permitted verbal consent for study participation where required. Participant confidentiality....

Access restricted. Please log in or start a trial to view this content.

Results

Study design and overall schematic
The excluded participants did not meet predefined eligibility criteria, had incomplete baseline imaging data, or lacked standardized longitudinal follow-up. Among the 187 included participants, complete 12-month outcome classification was available for all cases included in the primary analysis, although isolated intermittent missing observations at individual follow-up visits were accommodated within the mixed-effects modeling framework (Figure.......

Access restricted. Please log in or start a trial to view this content.

Discussion

This study evaluated an elastography-based approach for assessing treatment response after RFA of thyroid nodules by using elastography as a quantitative imaging biomarker associated with post-ablation stiffness change. The central proposal is that stiffness, measured by SWE and strain elastography, can serve as an early indicator of ablation effect and a longitudinal marker of post-ablation remodeling, complementing conventional volume-based endpoints. The findings support this concept at two levels. First, both SWE sti.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors declare no competing interests.

Acknowledgements

The authors are grateful to the Department of Endocrinology for assistance with clinical evaluation, follow-up coordination, and thyroid function assessment. Appreciation is also extended to the Interventional Radiology team for procedural support and peri-procedural patient care, and to the Department of Pathology for cytology review and diagnostic guidance when applicable. The contributions of the nursing staff, outpatient clinic coordinators, and study participants are sincerely acknowledged.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
3M Tegaderm Film DressingTegadermhttps://www.3m.com/3M/en_US/p/c/medical/bandages-dressings/film/i/health-care/medical/Adhesive dressing; Post-procedure site coverage.
Disposable syringeBecton DickinsonBD 309628Hydrodissection and local anesthetic administration
Grounding pads for RFA3M HealthcareModel 9547Single-use return electrodes compatible with RF.
High-frequency linear-array transducer (5–14 MHz)SuperSonic ImagineSL15-4 linear probeThyroid ultrasound and elastography acquisition
High-frequency linear-array ultrasound transducer (7–15 MHz)MindrayL11-3ULinear probe optimized for thyroid imaging and elastography.
IntelliVue Philips HealthcareMX450Patient monitoring system; ECG, SpO2, noninvasive BP monitor during RFA.
IntelliVue Philips HealthcareMP50Vital signs monitor; Continuous peri-procedural monitoring
Lidocaine hydrochloride injectionHospira Inc.NDC 0409-4276-17Local anesthesia before ablation
lme4 packageCRANRRID:SCR_015654Linear mixed-effects modeling in R.
lmerTest packageCRANRRID:SCR_015656Mixed model testing and p-values in R.
Microflex Powder-Free GlovesAnsell HealthcareAseptic barrier for procedural team.
Non-sterile ultrasound gelEcoGelCoupling medium for baseline and follow-up imaging.
Picture Archiving and Communication System (PACS)GE HealthcareCentricity PACSEnterprise-grade image storage and retrieval system.
Povidone-Iodine 10%BetadinePre-procedural antiseptic.
Precision Workstation DellT5820For image review and data analysis.
PrecisionGlide 22G–27GBD (Becton Dickinson)https://www.bd.com/en-us/products-and-solutions/productsNeedle set for local anesthesia/hydrodissection.
Premixed Saline Bag 500 mL (0.9% NaCl)Baxter HealthcareFluid for hydrodissection and flushing.
R statistical computing softwareR FoundationRRID:SCR_001905Statistical analysis environment.
RFA percutaneous cooled electrodeSTARmed Co., Ltd.Star RF Electrode 18-10s10FActive RFA electrode for thyroid ablation (TaeWoong Medical USA)
RStudio integrated development environmentPosit (formerly RStudio)RRID:SCR_000432IDE for R statistical analyses.
Shear-wave elastography software moduleMindraySWE Module (RESONA Series)Quantitative stiffness mapping in kPa within the US system.
Sterile drape kitMedline IndustriesDYNJP2500Sterile preparation for thyroid RFA procedure
Sterile gauze and swabsCovidienSterile Sponge KitUsed for skin prep and hemostasis.
Sterile normal salineBaxter Healthcare2B1324XHydrodissection during thyroid RFA
Sterile procedure drapes (Blue Drape Pack)Medline IndustriesStandard drape for sterile percutaneous RFA setup.
Sterile ultrasound gelAquasonic 100Conductive Gel 100 mLSterile coupling medium for US guidance.
Sterile ultrasound probe coverParker LaboratoriesModel 1001Sterile cover for intra-procedural imaging.
Strain elastography software moduleMindraySE Module (RESONA Series)Strain ratio calculation with integrated quality indicator.
Syringes (5/10/20 mL)BD (Becton Dickinson)Monoject SyringesFor anesthetic and hydrodissection delivery.
Three-way stopcockBD (Becton Dickinson)Model 305129Stopcock and tubing for controlled fluid management.
Thyroid RF ElectrodeSTARmed Co., Ltd.https://en.starmed4u.com/Internally cooled RF electrode; Radiofrequency ablation of thyroid nodules
Ultrasound coupling gelParker LaboratoriesAquasonic 100Ultrasound and elastography acquisition
Ultrasound imaging system with elastography capabilitySuperSonic ImagineAixplorerUsed for B-mode ultrasound, Doppler imaging, SWE, and strain elastography
VIVA Combo RF GeneratorSTARmed Co., Ltd.RF generator for percutaneous thyroid ablation (TaeWoong Medical USA)
VIVA RF GeneratorSTARmed Co., Ltd.Ultrasound-guided thyroid radiofrequency ablation
Xylocaine 1% 10 mLAstraZenecaLocal anesthetic (lidocaine) for procedural analgesia.

Reprints and Permissions

Tags

Medicineshear wave elastography